CLINICAL SIGNIFICANCE OF THE TP53 MUTATION STATUS IN DIFFUSE LARGE B-CELL LYMPHOMA

Objective: to reveal the clinical significance of the mutation status of the TP53 gene in the group of receiving rituximab therapy patients with diffuse large B-cell lymphoma (DLBCL) in Novosibirsk. Material and methods. A total of 74 patients with DLBCL, who have been hospitalized at the City Hemat...

Full description

Bibliographic Details
Main Authors: E. N. Voropaeva, T. I. Pospelova, M. I. Voevoda, V. N. Maksimov
Format: Article
Language:Russian
Published: Russian Academy of Sciences, Siberian Branch Publishing House 2019-03-01
Series:Сибирский научный медицинский журнал
Subjects:
Online Access:https://sibmed.elpub.ru/jour/article/view/105